Yumeng Wang

A targetable LIFR−NF-κB−LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis

Fan Yao, Yalan Deng, Yang Zhao et al. · Nature Communications · 2021 · 322 citations · Full text

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results

Changsong Qi, Chang Liu, Jifang Gong et al. · Nature Medicine · 2024 · 136 citations

Cancer Immunosurveillance, Gastrointestinal Oncology, Medicine +8

RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial

Qihan Fu, Yi Zheng, Weijia Fang et al. · EClinicalMedicine · 2023 · 62 citations · Full text

Single‐Cell Landscape Highlights Heterogenous Microenvironment, Novel Immune Reaction Patterns, Potential Biomarkers and Unique Therapeutic Strategies of Cervical Squamous Carcinoma, Human Papillomavirus‐Associated (HPVA) and Non‐HPVA Adenocarcinoma

Junjun Qiu, Xinyu Qu, Yumeng Wang et al. · Advanced Science · 2023 · 58 citations · Full text

Diagnostic Biomarkers, Immunology, Biological Microenvironments +21

Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial

Chang Liu, Zhi Peng, Yanqiao Zhang et al. · The Lancet · 2025 · 58 citations · Full text

Gastro-oesophageal Junction Cancer, Esophageal Cancer, Gastrointestinal Oncology +10